ARCHIVES

In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate

This article is from The Cancer Letter archive.

Vol. 17 No. 07 | February 15, 1991

Download PDF Visit The Full Archive

Related Articles

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

Minority Trial Participation A Matter of Access, Study Says

December 30, 2005

In Brief: House, Senate Differ On NCI Positions; Upton Says Viral Oncology research Will Be Continued

August 12, 1977

Implants Don’t Cause Cancer, Long-Term Study Finds

May 26, 2006

NCI, ACS Agree On Interim Mammography Guides Dropping Routine Use for Women Under Age 50

August 27, 1976

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

October 19, 2007